Cargando…
OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
CONTEXT: Male hypogonadism adversely affects body composition, bone mineral density (BMD), and metabolic health. A previous report showed that pre-treatment testosterone (T) levels of <200 ng/dL is associated with greater improvement in spine BMD with T therapy. However, to date, there is no stud...
Autores principales: | Aguirre, Lina, Armamento-Villarea, Reina, Ballato, Elliot, Chen, Rui, Colleluori, Georgia, Qualls, Clifford, Villareal, Dennis T, Deepika, Fnu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627336/ http://dx.doi.org/10.1210/jendso/bvac150.1415 |
Ejemplares similares
-
Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022) -
OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023) -
Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
por: Madhusoodanan, Vinayak, et al.
Publicado: (2019) -
Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studies
por: Spitz, Aaron, et al.
Publicado: (2016) -
Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)
por: van Rossum, Huub H., et al.
Publicado: (2023)